The Annals of Pharmacotherapy. 2006;40(7):1327-1335. In overdose situations, modified-release delivery systems may continue to release their active ingredients; therefore, the management of an ...
ROCKVILLE, MD – There is a need for the scientific community to explore the use of additional strength biowaivers for modified release (MR) drugs given the increasing market demand for these “patient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results